Merck vows to press ahead with Vioxx defense
9th Sep 2005, 23:26 GMT
On the eve of a second court battle over its arthritis drug Vioxx, Merck & Co. Inc. said it does not plan to enter into any global settlement of the thousands of Vioxx lawsuits it faces and is focused on “defending these cases one at a time.”
Latest news from MSNBC.com: Health:
- Hospitals race to improve heart attack care
- Diabetes drug may cut heart risks
- U.S. kids getting hardened arteries
- Mixed reviews for Vioxx successor
- Red meat raises breast cancer risk
- Genes may determine who survives trauma
- Drug-covered balloon to open arteries?
- Tamiflu takers: Watch out for bizarre behavior
- Backlash from too much flu vaccine?
- Diseased gums raise risk of pancreatic cancer